SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1784NBIX: PPS $2.21 little above 52 weeks low of $2.00!mlkr-11/9/2009
1783Seeking Alpha: Neurocrine Biosciences, Inc. Q3 2009 Earnings Conference Call Ocmopgcw-10/30/2009
1782<i>This prospectus relates to the resale from time to time of up to 7,814,scaram(o)uche-10/29/2009
1781I don't believe in giving restricted stock in the first place.rkrw-10/5/2009
1780You go to a development-stage company EXPECTING that there will be sacrifices. scaram(o)uche-10/5/2009
1779If it makes you feel any better, the shares were sold to cover taxes. Explanatrkrw-10/5/2009
1778I could not agree more. Disgraceful.mopgcw-10/5/2009
1777Bozigian, O'Brien and Grigoriadis all dumped 10b5-1 shares into an illiquid scaram(o)uche-10/5/2009
1776If the price of 3.64 on my screen represents a good trade (it probably isn'ttom pope-9/16/2009
1775Neurocrine Biosciences Secures Committed Equity Financing Facility PR Newswire -mopgcw-9/16/2009
1774Re. the last half hour of trading, obviously out of normal context....... I ascaram(o)uche-9/2/2009
1773I think the indemnity agreement is a very good thing since gross negligence woulBiotech Jim-9/1/2009
1772Chuckle. Yes.......scaram(o)uche-9/1/2009
1771better than re-pricing them...mopgcw-9/1/2009
1770Different. Thoughts??...... Item 1.01. Entry into a Material Definitive Agrescaram(o)uche-9/1/2009
1769<i>VMAT2 inhibitor into clinic in August......</i> Neurocrine Bioscscaram(o)uche-7/29/2009
1768Neurocrine Biosciences Presents Elagolix Data PR Newswire - Tuesday 06/16/2009 4mopgcw-6/20/2009
1767Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix keokalani'nui-5/18/2009
1766Interesting comment from Kevin Gorman on the recent conference call: "We wBiotech Jim25/12/2009
1765SeekingAlpha: Neurocrine Biosciences Inc. Q1 2009 Earnings Call Transcript May mopgcw-5/7/2009
1764Neurocrine Biosciences Reports First Quarter 2009 Results PR Newswire - Tuesday mopgcw-5/6/2009
1763DJ Neurocrine Biosciences Sees Costs Of $3M Related To Job Cuts DOW JONES NEWSWmopgcw-5/5/2009
1762yeah, got ya. thanks!scaram(o)uche-3/26/2009
1761Company also said before that, after minute 28:05 (paraphrase): We might just skeokalani'nui-3/26/2009
1760Discussion beginning at 49:05 of the conference call...... company intends to ascaram(o)uche-3/26/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News